Teva Pharmaceutical Industries ADR
(TEVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,946,000 | 2,226,000 | 1,038,000 | 2,879,000 | 1,096,000 |
| Receivables | 5,350,000 | 5,408,000 | 5,338,000 | 5,572,000 | 6,213,000 |
| Inventories | 3,966,000 | 4,371,000 | 5,053,000 | 5,502,000 | 5,012,000 |
| Income taxes - deferred | 735,000 | 993,000 | 1,084,000 | 1,142,000 | 966,000 |
| Other current assets | 491,000 | 1,398,000 | 1,207,000 | 1,260,000 | 1,166,000 |
| TOTAL | $18,398,000 | $14,396,000 | $13,720,000 | $16,355,000 | $14,453,000 |
| Non-Current Assets | |||||
| PPE Net | 6,544,000 | 6,535,000 | 6,635,000 | 6,315,000 | 5,947,000 |
| Intangibles | 26,700,000 | 23,920,000 | 25,457,000 | 26,601,000 | 28,609,000 |
| Other Non-Current Assets | 2,591,000 | 1,569,000 | 1,696,000 | 1,338,000 | 1,133,000 |
| TOTAL | $35,835,000 | $32,024,000 | $33,788,000 | $34,254,000 | $35,689,000 |
| Total Assets | $54,233,000 | $46,420,000 | $47,508,000 | $50,609,000 | $50,142,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,585,000 | 1,761,000 | 1,804,000 | 3,006,000 | 4,280,000 |
| Accounts payable and accrued liabilities | 1,918,000 | 3,171,000 | 3,317,000 | 3,376,000 | 3,572,000 |
| Accrued Expenses | 2,391,000 | N/A | N/A | N/A | N/A |
| Other current liabilities | 7,111,000 | 7,357,000 | 6,844,000 | 6,506,000 | 5,824,000 |
| TOTAL | $13,005,000 | $12,289,000 | $11,965,000 | $12,888,000 | $13,676,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 8,358,000 | 8,566,000 | 10,387,000 | 11,712,000 | 10,236,000 |
| Other Non-Current Liabilities | 1,186,000 | 1,122,000 | 1,289,000 | 1,346,000 | 1,268,000 |
| TOTAL | $11,301,000 | $10,776,000 | $12,907,000 | $14,854,000 | $14,123,000 |
| Total Liabilities | $24,306,000 | $23,065,000 | $24,872,000 | $27,742,000 | $27,799,000 |
| Shareholders' Equity | |||||
| Common Shares | 52,000 | 50,000 | 50,000 | 50,000 | 50,000 |
| Retained earnings | 14,851,000 | 14,436,000 | 12,535,000 | 12,346,000 | 11,284,000 |
| Other shareholders' equity | -1,797,000 | -1,301,000 | -20,000 | 82,000 | -441,000 |
| TOTAL | $29,927,000 | $23,355,000 | $22,636,000 | $22,867,000 | $22,343,000 |
| Total Liabilities And Equity | $54,233,000 | $46,420,000 | $47,508,000 | $50,609,000 | $50,142,000 |